Generated by GPT-5-mini| European Haematology Association | |
|---|---|
| Name | European Haematology Association |
| Abbreviation | EHA |
| Formation | 1992 |
| Type | Professional society |
| Headquarters | Amsterdam |
| Region served | Europe |
| Membership | clinicians, researchers |
European Haematology Association The European Haematology Association is a pan-European professional society bringing together clinicians, researchers, and institutions active in Hematology care and science, founded in 1992 with headquarters in Amsterdam. It functions alongside organizations such as American Society of Hematology, World Health Organization, European Commission, European Medicines Agency, and interacts with national bodies like British Society for Haematology, Deutsche Gesellschaft für Hämatologie und Onkologie, Société Française d'Hématologie, and Italian Society of Hematology to coordinate standards and policy.
The association grew from initiatives by leading figures affiliated with institutions such as Karolinska Institutet, University of Oxford, Institut Pasteur, Heidelberg University Hospital, and University College London who sought a continental forum comparable to the American Society of Hematology and the International Society on Thrombosis and Haemostasis. Early collaborations involved projects with the European Commission Framework Programmes, partnerships with the European Blood Alliance, and interactions with regulators including the European Medicines Agency and patient groups like European Patient Advocacy Groups. Over time the association expanded membership to clinicians from centers such as St Bartholomew's Hospital, Charité – Universitätsmedizin Berlin, Hospital Clínic de Barcelona, San Raffaele Hospital, and research laboratories at EMBL and CNRS.
The association's mission aligns with stakeholders including National Institutes of Health, European Cancer Organisation, EORTC, and specialty societies like European Society for Medical Oncology to improve patient care, advance translational research, and influence policy. Activities include guideline development in collaboration with bodies such as NICE, coordination with registries like European Cancer Information System, and capacity building with NGOs such as Médecins Sans Frontières for blood disorders in low-resource settings. The association advocates with institutions such as Council of Europe and funders like European Research Council to secure research funding and regulatory engagement.
Governance follows a constitution modeled on professional bodies including Royal College of Physicians, with a Governing Board, Executive Committee, and Scientific Council composed of representatives from universities and hospitals such as University of Cambridge, University of Milan, Trinity College Dublin, University of Zurich, Hospital do Mar, and research institutes like Max Planck Society. Administrative functions are based in offices comparable to those of European Society of Cardiology and coordinate with legal advisors in Brussels, financial auditors and partner organizations including World Federation of Hemophilia and patient organizations such as European Hematology Association Patient Advocacy groups.
Educational offerings mirror programs from institutions like Harvard Medical School, Mayo Clinic, Johns Hopkins Hospital, and European training networks funded through Marie Skłodowska-Curie Actions. The association runs clinical training, postgraduate courses, and online modules that reference consensus statements developed with the European LeukemiaNet, International Myeloma Working Group, European Society for Blood and Marrow Transplantation, and academic centers including Fred Hutchinson Cancer Center and Gustave Roussy. Research fellowships connect young investigators to laboratories such as Wellcome Sanger Institute, Francis Crick Institute, Institut Curie, and collaborative trials coordinated with cooperative groups like HOVON and EORTC.
Annual congresses attract presenters from major hospitals and universities including Mount Sinai Hospital, MD Anderson Cancer Center, Rigshospitalet, Karolinska University Hospital, and research institutes like Institut Gustave Roussy; these meetings often feature sessions organized with societies such as International Society for Experimental Hematology and American Association for Cancer Research. Publishing activity includes peer-reviewed journals and guidelines developed in concert with editorial boards drawing on expertise from The Lancet, New England Journal of Medicine, Blood (journal), and specialty journals tied to societies like British Journal of Haematology and Haematologica. The association also disseminates position papers for policymakers at venues such as European Parliament hearings.
Grant programs and awards reward excellence similar to prizes administered by organizations like the European Research Council, Marie Curie Actions, Wellcome Trust, and national academies such as the Royal Society and Académie Nationale de Médecine. Funding mechanisms support early-career investigators at institutions including Pasteur Institute, Institute of Cancer Research, and Radboud University Medical Center, sponsor clinical trial grants with cooperative groups such as HOVON and GIMEMA, and confer awards that recognize achievements comparable to honors from American Society of Hematology and European Society for Medical Oncology.
Category:Medical associations based in Europe